Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 5.12d

Adjusted Patient Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 11,177 99.6% 0.1% 11,177 98.7% 0.1% 34,288 91.9% 0.2% 56,493 77.3% 0.3%
Primary Diagnosis Glomerular Diseases 3,151 99.7% 0.1% 3,151 99.1% 0.2% 9,886 94.8% 0.3% 16,936 84.7% 0.5%
Diabetes 2,436 99.5% 0.1% 2,436 98.5% 0.2% 7,498 86.1% 0.6% 12,196 61.6% 0.9%
Hypertensive Nephrosclerosis 1,918 99.4% 0.2% 1,918 98.3% 0.3% 5,141 90.0% 0.6% 7,691 72.9% 1.0%
Polycystic Kidneys 1,253 99.7% 0.1% 1,253 99.5% 0.2% 3,715 96.4% 0.4% 5,649 87.1% 0.9%
Tubular and Interstitial Diseases 613 99.4% 0.3% 613 98.6% 0.4% 2,126 90.1% 0.9% 3,814 78.1% 1.2%
Renovascular & Other Vascular Diseases 235 99.3% 0.5% 235 98.2% 0.8% 1,072 90.8% 1.1% 1,989 70.7% 1.9%
Congenital, Rare Familial, & Metabolic Disorders 377 99.6% 0.4% 377 98.0% 0.9% 1,329 94.7% 1.0% 2,258 83.3% 1.9%
Neoplasms 43 + + 43 + + 144 88.8% 3.1% 240 71.0% 6.4%
Other 1,132 99.7% 0.2% 1,132 98.3% 0.4% 3,324 91.7% 0.7% 5,646 78.9% 1.1%
Unknown 19 100.0% 0.0% 19 96.1% 3.8% 53 79.7% 8.0% 74 65.4% 10.1%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader